Table 2.
Comparison of clinical parameters between the two groups determined by the hepatic steatosis criterion (b; CTL/S < 0.8).
| Patients with Hepatic Steatosis (n = 34) | Patients without Hepatic Steatosis (n = 305) | p-Value | ||
|---|---|---|---|---|
| Univariate Analysis | Multivariate Analysis | |||
| AST (IU/L) | 31.5 ± 16.5 | 25 ± 12 | 0.158 | |
| ALT (IU/L) | 40 ± 35 | 25 ± 14 | 0.043 | 0.571 |
| Fasting glucose (mg/dL) | 111.5 ± 36.5 | 98 ± 18 | <0.001 | 0.134 |
| HbA1c (%) | 6.25 ± 1.25 | 5.6 ± 0.5 | 0.82 | |
| Triglyceride (mg/dL) | 152 ± 146.5 | 95 ± 81 | <0.001 | 0.311 |
| Total cholesterol (mg/dL) | 207.5 ± 78 | 203 ± 55 | 0.005 | 0.436 |
| HDL (mg/dL) | 46 ± 17.75 | 57 ± 21 | 0.001 | 0.361 |
| LDL (mg/dL) | 120.5 ± 65.25 | 123 ± 50 | 0.754 | |
| Uric acid (mg/dL) | 5.35 ± 2 | 4.8 ± 1.85 | 0.02 | 0.214 |
| ALT/AST ratio | 1.3 ± 0.53 | 0.94 ± 0.36 | 0.003 | 0.037 |
| HSI | 38.02 ± 5.51 | 32.54 ± 6.78 | <0.001 | 0.037 |
| BMI (kg/m2) | 26 ± 3.93 | 23.6 ± 4.4 | <0.001 | 0.102 |
Data are median ± IQR values. AST: aspartate aminotransferase, ALT: alanine aminotransferase, HbA1c: hemoglobin A1c, HDL: high-density lipoprotein, LDL: low-density lipoprotein, HSI: hepatic steatosis index, BMI: body mass index, IQR: interquartile range.